PRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma

Recruiting

Phase 2

Radiotherapy & ImmunotherapyPRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT05546827

Conditions

Sinonasal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical resection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-03-30.